Patent ID: 11866472
Assignee: DAIICHI SANKYO COMPANY, LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The method according to claim 1, wherein the first Xaa (X1) is Asp, Glu, Ser, Gly, or Ile, the second Xaa (X2) is Ala, Gly, Leu, Ser or Thr, the third Xaa (X3) is Asp, His, Lys, Met or Gln, the fourth Xaa (X4) is Asp, Phe, His, Ser or Tyr, the fifth Xaa (X5) is Ala, Asp, Glu, Met or Asn, the sixth Xaa (X6) is Met or Trp, the seventh Xaa (X7) is Gln, Trp, Tyr or Val, the eighth Xaa (X8) is Phe, Leu or Tyr, the ninth Xaa (X9) is Phe or Tyr, the tenth Xaa (X10) is Ala, Glu, Met or Val, and the eleventh Xaa (X11) is Ala, Thr or Val in the amino acid sequence shown in SEQ ID NO: 30 comprised in the peptide.